Keyphrases
50% Inhibitory Concentration
11%
Activity in Vivo
11%
Breath Test
44%
Concomitant Treatment
11%
Continuous Intravenous Infusion
11%
Cytochrome P450 3A (CYP3A)
22%
Derived Material
11%
Dose Adjustment
11%
Drug Interactions
100%
Erythromycin
44%
Experiment in Vitro
100%
Human Studies
100%
IC50
11%
Inter-patient Variability
22%
Inter-variability
11%
Ketoconazole
100%
Metabolism in Vitro
11%
Ovarian Cancer Patients
11%
Paclitaxel
100%
Peak Plasma Concentration
11%
Pharmacokinetics
22%
Plasma Concentration
33%
Plasma Drug Concentration
11%
Single Oral Dose
11%
Ultra-high Performance Liquid Chromatography (UHPLC)
11%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Study
11%
CYP3A
22%
Drug Concentration
11%
Drug Interaction
100%
Erythromycin
44%
Human Study
100%
Hyperbarism
11%
IC50
22%
Ovary Cancer
11%
Paclitaxel
100%
Neuroscience
Erythromycin
44%
Ketoconazole
100%